Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
10.47
+0.33 (3.25%)
Jun 18, 2025, 4:00 PM - Market closed
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $1.59 billion as of June 18, 2025. Its market cap has increased by 212.84% in one year.
Market Cap
1.59B
Enterprise Value
1.58B
1-Year Change
212.84%
Ranking
Category
Stock Price
$10.47
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $1.59B, a decrease of -66.69%. That is a compound annual growth rate of -16.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.09B |
| Johnson & Johnson | 363.92B |
| Novo Nordisk | 334.60B |
| AbbVie | 329.03B |
| UnitedHealth Group | 281.39B |
| Abbott Laboratories | 230.75B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |